Your Cart ( 1 Item )

• Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and Tofacitinib
  August 2015 | Volume 14 | Issue 8 | Original Article | 786 | Copyright © August 2015
  Rachel McAndrew MD,^a,b Ethan Levin MD,^b and John Koo MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs